unknown
Stage
1
Investors
About
Aeovian Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company developing targeted, selective small molecule drugs to restore cellular metabolic control and treat rare genetic and age-related diseases, including CNS-penetrant mTORC1 inhibitors.
Explore Aeovian Pharmaceuticals Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.